Results From VELOUR, a Phase 3 Study of Aflibercept (A) Versus Placebo (pbo) in Combination with FOLFIRI for the Treatment of Patients (pt) with Previously Treated Metastatic Colorectal Cancer (MCRC)

• DOI: 10.1016/s0959-8049(11)70105-8
• Publication Date: 2011-09-23T15:57:32Z
• Authors: J. Tabernero; E. Van Cutsem; R. Lakomy; J. Prausova; P. Ruff; G. Van Hazel; V Moiseyenko; D. Ferry; J. McKendrick; K. Soussan-Lazard; E. Boelle; C. Allegra
• Keywords: 03 medical and health sciences; 0302 clinical medicine